# Mitochondrial-targeted Antioxidant Supplementation for Improving Age-related Vascular Dysfunction in Humans

> **NCT04851288** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Colorado, Boulder** · enrollment: 112 (estimated)

## Conditions studied

- Aging

## Interventions

- **DIETARY_SUPPLEMENT:** MitoQ
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04851288
- **Lead sponsor:** University of Colorado, Boulder
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-04-02
- **Primary completion:** 2025-12
- **Final completion:** 2026-12
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2025-11-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04851288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04851288, "Mitochondrial-targeted Antioxidant Supplementation for Improving Age-related Vascular Dysfunction in Humans". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04851288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*